(2023)
Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045.
INTERNATIONAL JOURNAL OF CANCER.
153,
12
(2023)
A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis.
BMC CANCER.
23,
1
(2023)
Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: Primary analysis in the original cohort of KGOG3046/TRU-D.
JOURNAL FOR IMMUNOTHERAPY OF CANCER.
11,
10
(2023)
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4.
NATURE COMMUNICATIONS.
14,
1
(2023)
The Effect of Intrathecal Morphine on Postoperative Opioid Consumption in Patients Undergoing Abdominal Surgery for Gynecologic Malignancy: A Randomized Sham-Controlled Trial.
ANESTHESIA AND ANALGESIA.
137,
3
(2023)
Survival outcomes of laparoscopic versus open radical hysterectomy in early cervical cancer with incidentally identified high-risk factors.
GYNECOLOGIC ONCOLOGY.
174,
(2023)
Arteriovenous Malformation Associated with Intravenous Leiomyomatosis of the Uterus: Characteristic CT Findings and Treatment by Embolization and Surgery.
Journal of Vascular and Interventional Radiology.
34,
1
(2023)
Role of salvage radiotherapy for recurrent ovarian cancer.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER.
33,
1
(2022)
Invisible cervical cancers on MRI: Can the type of histology (SCC versus non-SCC) influence surgical planning?.
FRONTIERS IN ONCOLOGY.
12,
-
(2022)
Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER.
32,
12
(2022)
Role of reactive thrombocytosis after primary cytoreductive surgery in advanced ovarian cancer.
FRONTIERS IN ONCOLOGY.
12,
(2022)
Changes in subcellular localization of Lysyl-tRNA synthetase and the 67-kDa laminin receptor in epithelial ovarian cancer metastases.
CANCER BIOMARKERS.
35,
1
(2022)
The Role of Conization before Radical Hysterectomy in Cervical Cancer including High Risk Factors of Recurrence: Propensity Score Matching.
CANCERS.
14,
16
(2022)
Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial.
JOURNAL OF GYNECOLOGIC ONCOLOGY.
33,
4
(2022)
Impact of no residual disease on postoperative computed tomography on survival in patients with optimally debulked advanced high-grade serous ovarian cancer during upfront surgery.
GYNECOLOGIC ONCOLOGY.
165,
3
(2022)
Prognostic Significance of HER3 Expression in Patients with Cervical Cancer.
CANCERS.
14,
9
(2022)
Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial protocol.
BMC CANCER.
22,
1
(2022)
Clinical outcome of pulmonary lymphangitic carcinomatosis in gynecologic malignancy: A single-institution experience.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY.
61,
2
(2022)
Comparative performance of various human papillomavirus assays available in Korea for detecting cervical intraepithelial neoplasia.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH.
48,
1
(2022)
Effect of Waiting Time from Pathological Diagnosis to Definitive Concurrent Chemoradiation for Cervical Cancer on Overall Survival.
CANCER RESEARCH AND TREATMENT.
54,
1
학술회의논문
(2018)
Help patients stop CINV with golden standard of anti-emetics agent (12:10~12:30).
대한부인종양학회 제24차 추계심포지엄.
대한민국
(2018)
TCGA genomic classification of endometrial cancer (09:00~09:20).
KGOG 2018 Summer Workshop Uterine Cancer.
대한민국
(2018)
Introduction of ERAS in gynecologic oncology (15:40~16:00_.
대한부인종양학회 제33차 춘계학술대회.
대한민국
(2017)
Chemoradio-prediction model using reverse phase protein arrays in locally advanced cervical cancer (16:30~16:50).
제23차 대한부인종양학회 추계심포지엄.
대한민국
(2017)
Comparison of RNA-seq and microarray of gene expression signatures as a predictor of survival in six selected cancers.
제103차 대한산부인과학회 학술대회.
대한민국
(2017)
Differences in correlation of progression-free survival and overall survival by clinical variables in ovarian cancer.
제103차 대한산부인과학회 학술대회.
대한민국
(2017)
Differences in correlation of progression-free survival and overall survival by clinical variables in epithelial ovarian cancer.
25th Asian & Oceanic Congress of Obstetrics and Gynaecology.
홍콩
(2017)
Molecular signature for lymph node metastasis predicts survival in epithelial ovarian cancer.
제32차 대한부인종양학회 춘계학술대회.
대한민국
(2017)
Prognostic model for disease-free survival, lymphatic and/or hematogenous recurrence, in patients with early stage cervical cancer-treated with radical hysterectomy: A Korean Gynecologic Oncology Group Study (15:00~15:20).
The 56th Annual Congress of Taiwan Association of Obstetrics and Gynecology.
태국
(2015)
Differences in survival outcome of recurrent epithelial ovarian cancer patients with secondary cytoreductive surgery diagnosed recurrence by different initial diagnostic method.
The 4th Biennial Meeting of ASGO.
대한민국
(2015)
Feasibility and outcomes of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer.
The 4th Biennial Meeting of ASGO.
대한민국
(2015)
HER2 as a novel therapeutic target for cervical cancer.
The 4th Biennial Meeting of ASGO.
대한민국
(2015)
Outcomes of laparoscopic fertility-spariang surgery in presumed early-stage epithelial ovarian cancer.
The 4th Biennial Meeting of ASGO.
대한민국
(2015)
Prognostic factors affecting survival in cervical cancer patients who had recurrent parenchymal lung lesion.
The 4th Biennial Meeting of ASGO.
대한민국
(2015)
Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma.
The 4th Biennial Meeting of ASGO.
대한민국
(2015)
Gestational choriocarcinoma mimicking the degenerative uterine myoma in MRI finding.
제101차 대한산부인과학회 학술대회.
대한민국
(2015)
Glassy cell carcinoma of the uterine cervix: A rare case..
제101차 대한산부인과학회 학술대회.
대한민국
(2015)
HER2 as a Novel Therapeutic Target for Cervical Cancer.
제101차 대한산부인과학회 학술대회.
대한민국
(2015)
Sphingosing kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer.
제101차 대한산부인과학회 학술대회.
대한민국
